EntryPoint Capital’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,252
Closed -$30.4K 833
2024
Q3
$30.4K Buy
+15,252
New +$30.4K 0.02% 593